Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 15/20 | 0.82 |
| ▸ | CDK2 | P24941 | 9/20 | 0.82 |
| ▸ | CCNB1 | P14635 | 7/20 | 0.82 |
| ▸ | CCNB2 | O95067 | 5/20 | 0.82 |
| ▸ | CCNB3 | Q8WWL7 | 5/20 | 0.82 |
| ▸ | CCNE1 | P24864 | 5/20 | 0.80 |
| ▸ | CDK9 | P50750 | 3/20 | 0.79 |
| ▸ | CDK5 | Q00535 | 8/20 | 0.74 |
| ▸ | CDK4 | P11802 | 3/20 | 0.74 |
| ▸ | CCND1 | P24385 | 3/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.74 |
| ▸ | MAPT | P10636 | 2/20 | 0.74 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.74 |
| ▸ | TP53 | P04637 | 2/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.74 |
| ▸ | TSHR | P16473 | 2/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1443682 | 0.90 | CDK1 (1.00) | CDK1CDK2CCNB1CCNB2CCNB3 | |
| SCHEMBL3721146 | 0.90 | CDK1 (1.00) | CDK1CDK2CCNB1CCNB2CCNB3 | |
| SCHEMBL5827674 | 0.89 | CDK2 (1.00) | CDK1CDK2CCNB1CCNB2CCNB3 | |
| SCHEMBL3302130 | 0.88 | CDK2 (1.00) | CDK1CDK2CCNB1CCNE1CDK9 | |
| SCHEMBL3677785 | 0.88 | CDK2 (1.00) | CDK1CDK2CCNB1CCNE1CDK9 | |
| SCHEMBL13408166 | 0.87 | CDK2 (0.82) | CDK1CDK2CCNB1CCNB2CCNB3 | |
| Purvalanola SCHEMBL29360281 | 0.85 | CDK5 (1.00) | CDK1CDK2CCNB1CCNB2CCNB3 | |
| Purvalanola SCHEMBL30375366 | 0.85 | CDK5 (1.00) | CDK1CDK2CCNB1CCNB2CCNB3 | |
| Purvalanola SCHEMBL1217069 | 0.85 | CDK5 (1.00) | CDK1CDK2CCNB1CCNB2CCNB3 | |
| Purvalanola SCHEMBL3311119 | 0.85 | CDK5 (1.00) | CDK1CDK2CCNB1CCNB2CCNB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1246829-A1 | NOVEL HETEROCYCLES | ARIAD PHARMACEUTICALS, INC. (US) | 2002-10-09 | — | — | EP | disclosed |
| US-20020103161-A1 | Novel heterocycles | ARIAD PHARMACEUTICALS, INC. | 2002-08-01 | — | — | US | disclosed |
| WO-2001044258-A1 | NOVEL HETEROCYCLES | ARIAD PHARMACEUTICALS, INC. (US) | 2001-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020103161-A1 | Novel heterocycles | BMP2, SOST, BMP4 | CDK1 93/4885CDK2 74/4885CCNB1 973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.